American Parkinson Disease Association (APDA) Center for Advanced Research
The University of Pittsburgh is home to an American Parkinson Disease Association (APDA) Center for Advanced Research. The Center is directed by Dr. Tim Greenamyre, along with a comprehensive team of experts.
APDA Centers for Advanced Research must meet the highest academic standards and be distinguished leaders in the field of Parkinson’s disease (PD) research. There are nine such Centers across the country.
The funding of this Center supports a large research program, which includes: Neurologists, Neuroscientists, Postdoctoral Fellows, Graduate and Undergraduate Students and Movement Disorders Fellows, as well as Physician Assistants, Nurse and Clinical Research Coordinators. Projects range from basic laboratory bench studies to translational testing of new therapeutic strategies to clinical trials of new treatments for people with PD. The University of Pittsburgh Center has experience with both experimental and clinical gene therapy studies.
The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to assist the more than one million people in the United States with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $282 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join APDA in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through its network of Chapters and Information & Referral (I&R) Centers, as well as its national Research Program, which includes Centers for Advanced Research like this one, please visit www.apdaparkinson.org.
Parkinson’s disease affects more than one million people in the United States, with at least 90,000 new cases diagnosed each year. The chronic and progressive neurological condition is the second most common neurodegenerative aging disorder, after Alzheimer’s disease.
For more information contact:
· Medical Director: J Timothy Greenamyre, MD, PhD
· Phone: 412.648.9793
· E-mail: PIND@pitt.edu